Genetesis logo — Building the future of cardiac imaging by advancing the fiel...

Genetesis

Building the future of cardiac imaging by advancing the field of MCG.

Founded 2013 United States Mason, United States 36 employees Series C Total: $35.81M Health Care, Medical Devices

General Information

Company Name Genetesis
Founded Year 2013
Location United States Mason, United States
Employees 36
Industries Health Care, Medical Devices
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Genetesis. To contact Genetesis, visit genetesis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Genetesis

Genetesis is a rapidly growing medical imaging company founded in 2013 and is headquartered in the United States . The company's slogan "Building the future of cardiac imaging by advancing the field of MCG" reflects its focus on leveraging data science and biomagnetism in the fight against cardiovascular disease. In October 2022, Genetesis secured a significant $17.50M Series C investment from a group of notable investors including CincyTech, Ohio Innovation Fund, Mithril Capital, JobsOhio, Wormhole Capital, and Cercano Management . This funding is expected to fuel the company's continued innovation and expansion within the Health Care and Medical Devices industries .

Taxonomy: Computational Medicine, Diagnostics, Cardiac Imaging, Emergency Medicine, Cardiology, Chest Pain, Magnetocardiography

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $17.50M 6
CincyTech, Ohio Innovation Fund +4
06 Oct 2022
Venture Round $150.00K 1
HeartX
18 Oct 2021
Series B Undisclosed 1
10x Capital
11 Mar 2021
Series B $9.20M 4
CincyTech, Ohio Innovation Fund +2
21 Apr 2020
Series A $7.50M 4
CincyTech, Ohio Innovation Fund +2
05 Jun 2018
Grant Undisclosed 1
MedTech Innovator
01 May 2017
Seed Round $1.20M 4
CincyTech, LOUD Capital +2
14 Nov 2016
Pre Seed Round $260.00K 1
43North
30 Oct 2014

Genetesis Alternatives & Competitors

View All Alternatives
Genetesis vs

Effortlessly Achieve Comprehensive Cardiac Imaging with One Click

Series A
11-50 employees
AI, Health Care
Genetesis vs

Positron Corporation is a medical technology company that co-develops, manufactures, and sells state...

Post-IPO Equity
28 employees
Biotechnology, Health Care
Genetesis vs

Leveraging quantum technology to enable imaging of cell metabolism via hyperpolarized MRI

150 employees
Biopharma, Biotechnology

FAQ About Genetesis

Building the future of cardiac imaging by advancing the field of MCG.
Genetesis was founded in 2013.
Genetesis is headquartered in Mason, United States.
Genetesis operates in Health Care and Medical Devices. Its work centres on Computational Medicine, Diagnostics, Cardiac Imaging and Emergency Medicine.
Genetesis has approximately 36 employees.
Genetesis has completed 8 funding rounds, raising a total of $35.81M. The latest funding stage is Series C.
Top alternatives and competitors to Genetesis include HeartVista, Positron Corporation, NVision Quantum Technologies, Creavo Medical Technologies Ltd, SpectraWAVE, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genetesis and HeartVista are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Genetesis, https://bouncewatch.com/company/genetesis, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes